MedTrace Logo

Proton Beam Therapy for Treatment of Hepatocellular Carcinoma

NCT00614913 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2012-08-20

Study results available
· View outcomes & findings →

Summary

This study is designed to evaluate the possible benefits and side effects of the use of proton therapy for patients with hepatocellular carcinoma.

Conditions

Interventions

RADIATION

Proton radiation therapy

A total dose of 63 Gy will be delivered in 15 equally divided daily fractions over a 3 week coarse as an out-patient.

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • David A Bush, MD · Loma Linda University Dept. of Radiation Medicine

  • Jerry D Slater, MD · Loma Linda University Department of Radiation Medicine

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1998-05-31
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00614913 on ClinicalTrials.gov